title: Inhibition of Cervical Cancer by Promoting IGFBP7 Expression Using Ellagic Acid from Pomegranate Peel.
abstract: BACKGROUND The aim of this study was to explore the mechanism by which cervical cancer is inhibited by promoting IGFBP7 expression using ellagic acid from pomegranate peel extract. MATERIAL AND METHODS HeLa cells were divided into 6 groups: control group (NC), blank control group (BL), and IGFBP7 overexpression group (IGFBP7), and 2.5 uM, 5. 0 uM, and 10.0 uM ellagic acid-treated groups. The cell proliferation ability was detected and the degree of invasion in the 6 groups was measured by Transwell assay. The expression levels of IGFBP7 and AKT/mTOR in the 6 groups of cells were detected by RT-PCR technique. RESULTS Compared with NC and BL groups, The IGFBP7 gene expressions of the IGFPB7 and ellagic acid-treated groups were significantly increased (P<0.05). There was a dose-effect dependence in the ellagic acid-treated groups. The invasion ability of the IGFBP7 group and ellagic acid-treated groups was significantly lower than that of NC and BL groups in HeLa cells (P<0.05). The apoptosis rate of the IGFBP7 group and ellagic acid-treated groups was significantly higher than that of the NC and BL groups in HeLa cells (P<0.05). AKT and mTOR mRNA and protein expressions of the IGFBP7 group and ellagic acid-treated groups were significantly lower than that of the NC and BL groups (P<0.05). There was a dose-effect dependence in the ellagic acid-treated groups. CONCLUSIONS The ellagic acid in pomegranate peel extract can inhibit the AKT/mTOR signaling pathway by enhancing the expression level of IGFBP7, which can inhibit the HeLa cells in cervical cancer.
authors.affiliation: Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
authors.forename: Hongjun
authors.initials: H
authors.lastname: Guo
authors.affiliation: Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
authors.forename: Dongya
authors.initials: D
authors.lastname: Zhang
authors.affiliation: Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
authors.forename: Qingrui
authors.initials: Q
authors.lastname: Fu
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D004610:Ellagic Acid / Q000494:pharmacology*; D005260:Female; D006367:HeLa Cells; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins / Q000096:biosynthesis*; D029561:Lythraceae / Q000737:chemistry*; D010936:Plant Extracts / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D002583:Uterine Cervical Neoplasms / Q000378:metabolism* / Q000517:prevention & control*
chemical_list: D018969:Insulin-Like Growth Factor Binding Proteins; D010936:Plant Extracts; C102529:insulin-like growth factor binding protein-related protein 1; D004610:Ellagic Acid